Patient centered outcomes are very important to health plans. Satisfaction with pharmacy/prescription benefits and patients health status are two such outcomes that managed care organizations consider consequential. OBJECTIVE: The purpose of this study was to examine the relationship between general health status and satisfaction with pharmacy benefits for patients taking selective serotonin reuptake inhibitors (SSRIs). Additionally, the study compared results across three types of health plans, namely indemnity, HMO, and PPO. METHOD: A survey instrument was administered to 2,000 patients randomly identified from a pharmacy claims database. The survey instrument included the SF-12 scale and questions measuring patient satisfaction with pharmacy benefit services. Patient satisfaction was measured using a seven-point, eight item scale, where 7 = extremely satisfied and 1 = extremely dissatisfied. Demographic variables such as age, gender, SSRI drug taken, and type of health plan were obtained from the claims database. RESULTS: Preliminary data of 327 completed surveys were coded and analyzed using statistical tests. A multivariate analysis of variance test indicated no significant effect of SSRI drug taken or the type of health plan enrolled on variables measured (p>0.05). There was also no significant association between scores of the SF-12 scale (both the physical and mental component ) and patient satisfaction with pharmacy benefits. In general, patient were very satisfied (5.83 ± 0.74) with the pharmacy/prescription benefits and they indicated their health status to be very good (3.45 ± 0.92). The physical and mental component of the SF-12 scores were comparable to those of the national average, 52.68 ± 11.99 and 52.38 ± 18.66, respectively. CONCLUSIONS: The results of this study indicate that consumers are very satisfied with the services offered by the pharmacy/prescription benefit.